We serve Chemical Name:3-pentyn-2-ol CAS:58072-60-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-pentyn-2-ol
CAS.NO:58072-60-9
Synonyms:S982;rac-3-pentyn-2-ol;pent-3-yne-2-ol;rac-pent-3-yn-2-ol
Molecular Formula:C5H8O
Molecular Weight:84.11640
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:138-140ºC(lit.)
Density:0.900 g/mL at 20ºC(lit.)
Index of Refraction:n20/D 1.448
PSA:20.23000
Exact Mass:84.05750
LogP:0.39050
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1987 3/PG 3
Packing Group:
Contact us for information like S982 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,rac-pent-3-yn-2-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,rac-pent-3-yn-2-ol Use and application,S982 technical grade,usp/ep/jp grade.
Related News: Hong Kong confirmed its 14th coronavirus case late Saturday. The patient, an 80-year-old man, had traveled for a few hours to mainland China in early January, and later spent several days on a cruise ship in Japan with more than 3,000 passengers and employees. 3-pentyn-2-ol manufacturer Hong Kong confirmed its 14th coronavirus case late Saturday. The patient, an 80-year-old man, had traveled for a few hours to mainland China in early January, and later spent several days on a cruise ship in Japan with more than 3,000 passengers and employees. 3-pentyn-2-ol supplier Hong Kong confirmed its 14th coronavirus case late Saturday. The patient, an 80-year-old man, had traveled for a few hours to mainland China in early January, and later spent several days on a cruise ship in Japan with more than 3,000 passengers and employees. 3-pentyn-2-ol vendor This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care. 3-pentyn-2-ol factory Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching.
